F. Vega

Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features

T. McDonnell, H. Kantarjian, G. Garcia-Manero, 2010, Leukemia.

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies

D. Gilliland, T. Manshouri, A. Quintás-Cardama, 2008, Leukemia.

Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents.

S. Panowski, R. Başar, K. Rezvani, 2024, Virchows Archiv : an international journal of pathology.

Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

P. Farinha, M. Boyle, B. Meissner, 2024, American journal of hematology.

SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions.

Matt Teater, P. Reville, N. El-Mallawany, 2024, Cancer cell.

Bridging Clinicopathologic Features and Genetics in Follicular Lymphoma: Towards Enhanced Diagnostic Accuracy and Subtype Differentiation.

F. Climent, F. Vega, Jan Bosch-Schips, 2024, Human pathology.